With the aging of the US population, the number of persons with age-related macular degeneration (AMD) is expected to rapidly increase in coming decades. Currently, more than 11 million persons are affected by this sight-threatening condition, and the prevalence is expected to double by 2050.1,2 Rates of other common ocular diseases of aging, such as cataract, glaucoma, and diabetic retinopathy, are also expected to rapidly increase. This projection begs the question of how eye care professionals are going to be able to continue to provide high-quality and timely care to all these patients in the years to come.
Pershing S, Stein JD. Determining the Value of Home Monitoring of Patients With Age-Related Macular Degeneration. JAMA Ophthalmol. 2017;135(5):459–460. doi:10.1001/jamaophthalmol.2017.0133
Customize your JAMA Network experience by selecting one or more topics from the list below.